731 related articles for article (PubMed ID: 24316488)
21. A genetic variant in pre-miR-27a is associated with a reduced breast cancer risk in younger Chinese population.
Zhang N; Huo Q; Wang X; Chen X; Long L; Jiang L; Ma T; Yang Q
Gene; 2013 Oct; 529(1):125-30. PubMed ID: 23954879
[TBL] [Abstract][Full Text] [Related]
22. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis.
Li X; Kong X; Jiang L; Ma T; Yan S; Yuan C; Yang Q
Cell Physiol Biochem; 2014; 33(1):165-72. PubMed ID: 24481145
[TBL] [Abstract][Full Text] [Related]
23. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
Bayram S; Sümbül AT; Dadaş E
Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
[TBL] [Abstract][Full Text] [Related]
25. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
26. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
[TBL] [Abstract][Full Text] [Related]
27. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
[TBL] [Abstract][Full Text] [Related]
28. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
29. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Naidu R; Har YC; Taib NA
J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
[TBL] [Abstract][Full Text] [Related]
30. Association of interleukin-10 gene variation with breast cancer prognosis.
Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
[TBL] [Abstract][Full Text] [Related]
31. Significant association of caveolin-1 (CAV1) genotypes with breast cancer in Taiwan.
Liu LC; Su CH; Wang HC; Tsai CW; Chang WS; Ho CY; Wu CI; Li FJ; Lin CH; Lane HY; Bau DT
Anticancer Res; 2011 Oct; 31(10):3511-5. PubMed ID: 21965771
[TBL] [Abstract][Full Text] [Related]
32. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
Anders CK; Hsu DS; Broadwater G; Acharya CR; Foekens JA; Zhang Y; Wang Y; Marcom PK; Marks JR; Febbo PG; Nevins JR; Potti A; Blackwell KL
J Clin Oncol; 2008 Jul; 26(20):3324-30. PubMed ID: 18612148
[TBL] [Abstract][Full Text] [Related]
33. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
Canbay E; Eraltan IY; Cercel A; Isbir T; Gazioglu E; Aydogan F; Cacina C; Cengiz A; Ferahman M; Zengin E; Unal H
Anticancer Res; 2010 Jul; 30(7):3093-8. PubMed ID: 20683061
[TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
35. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
[TBL] [Abstract][Full Text] [Related]
36. Investigation of prognostic value of polymorphisms within estrogen metabolizing genes in Lithuanian breast cancer patients.
Savukaitytė A; Ugenskienė R; Jankauskaitė R; Čereškevičius D; Šepetauskienė E; Juozaitytė E
BMC Med Genet; 2015 Feb; 16():2. PubMed ID: 25648141
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
38. CCL22 16C/a genetic variation is not associated with breast carcinoma in Southern Iranian population.
Erfani N; Moghaddasi-Sani F; Razmkhah M; Haghshenas MR; Talei A; Ghaderi A
Iran J Immunol; 2012 Dec; 9(4):226-33. PubMed ID: 23268288
[TBL] [Abstract][Full Text] [Related]
39. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
